Commentary

D1.456 Large companies

Corporate tax
Corporate tax | Commentary

D1.456 Large companies

Corporate tax | Commentary

D1.456 Large companies

Vaccine research relief for large companies was abolished in relation to expenditure incurred on or after 1 April 2017. The provisions in this article apply to large companies for expenditure incurred before 1 April 2017.

VRR is given in addition to the existing R&D relief for large companies1.

A large company can obtain relief under the vaccine research scheme by claiming a deduction of 140% (before 1 August 2008, 150%) of the qualifying expenditure on vaccine research2.

For claims made after 1 August 2008, the claim must include a declaration that the availability of the relief claimed has resulted

To continue reading
View the latest version of this document, as well as thousands of others like it, sign in to TolleyLibrary or register for a free trial